TANG CAPITAL MANAGEMENT LLC Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$584.5B
Holdings
12
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (12 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 14,075,269 | $366.4B | 62.68% | |
| 2 | HRTXHERON THERAPEUTICS INC | 5,514,096 | $102.0B | 17.45% | |
| 3 | —LA JOLLA PHARMACEUTICAL CO | 4,938,893 | $43.5B | 7.44% | |
| 4 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $34.5B | 5.91% | |
| 5 | —AVROBIO INC | 829,121 | $11.7B | 2.00% | |
| 6 | CELGCELGENE CORP | 111,844 | $11.1B | 1.90% | |
| 7 | PBYIPUMA BIOTECHNOLOGY INC | 349,400 | $3.8B | 0.64% | |
| 8 | —NUCANA PLC | 500,000 | $3.6B | 0.62% | |
| 9 | GTHXEURG1 THERAPEUTICS INC | 150,000 | $3.4B | 0.58% | |
| 10 | PRTAPROTHENA CORP PLC | 423,823 | $3.3B | 0.57% | |
| 11 | OPHTEURIVERIC BIO INC | 600,000 | $672.0M | 0.11% | |
| 12 | —CELLECTAR BIOSCIENCES INC | 235,701 | $471.0M | 0.08% |